MedTrace Logo

The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents

NCT07097610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-07-31

No results posted yet for this study

Summary

This study aims to investigate the effect of mosaic puzzle application on nomophobia in middle school children aged 12-14.

The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks, at a time deemed appropriate by the school and under the supervision of the researcher. The control group children will not be given any intervention; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study.

Hypothesis 1: The intervention group's level of nomophobia is lower than that of the control group.

Conditions

  • Nomophobia
  • Puzzle Activity
  • Child
  • Dependence
  • Smart Phone Addiction

Interventions

OTHER

Mosaic Puzzle Intervention

This study aims to investigate the effect of mosaic puzzle application on nomophobia in adolescents. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks at a time deemed appropriate by the school under the supervision of the researcher. The control group children will not be given any application; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study.

Sponsors & Collaborators

  • Pamukkale University scientific research project department

    collaborator UNKNOWN

  • Rabia Nur TEKİ KESKİN

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-15
Primary Completion
2025-03-15
Completion
2025-05-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07097610 on ClinicalTrials.gov